Send to

Choose Destination
Neurochem Res. 1996 Jan;21(1):19-25.

A microdialysis study in rat brain of dihydrokainate, a glutamate uptake inhibitor.

Author information

Norwegian Defence Research Establishment, Division for Environmental Toxicology, Kjeller, Norway.


Microdialysis in neostriatum of anaesthetized rats was performed to study effects on amino acid efflux of the glutamate uptake-inhibitor dihydrokainate (DHK). Both basal and K+-evoked (100 mM) efflux of glutamate increased in the presence of DHK. The increase in the basal glutamate efflux occurred at lower DHK concentrations than during K+-depolarization (when the extracellular glutamate concentration was several-fold higher), confirming that DHK is a competitive inhibitor. The increase in basal efflux caused by DHK did not exhibit Ca(2+)-dependency, whereas 50% of the increase in glutamate efflux during K+-depolarization was Ca(2+)-dependent. The Ca(2+)-dependent efflux is related to transmitter release, whereas the Ca(2+)-independent efflux is probably due to metabolic events and/or transport of DHK into cells in exchange for glutamate. Taurine efflux in response to DHK increased both during basal conditions and K+-depolarization, probably secondary to the increase in glutamate concentration, whereas aspartate, GABA, glutamine and alanine effluxes did not change.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center